Drug Database
Back to search

Netherlands· NL-a233c982b218

Jumbo Koortslipcrème Aciclovir 50 mg/g, crème

A aciclovir product containing aciclovir, registered in Netherlands by Healthypharm B.V.. The same ATC class is registered in 13 of our 19 countries.

ATC D06BB03

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedJumbo Koortslipcrème Aciclovir 50 mg/…ATCD06BB03REGISTER NO.NL-a233c982b218PACKS LISTED1CHECKEDSeptember 29, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about aciclovirAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Aciclovir is registered in 13 of 19 countries.

Countries holding a registration under ATC D06BB03 (aciclovir), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 7 of them publish a price we can compare per daily dose
Search aciclovir products by name

Aciclovir · ATC D06BB03

13 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Germany
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of aciclovir costs, country by country.

Normalised to the WHO defined daily dose (25 mg), the median price runs from $0.043 in France to $0.18 in Switzerland — a ×4.2 gap.

  • 3 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Aciclovir · price per daily dose (25 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$0.18
  • ES Spain$0.054
  • FR France$0.043
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

CBG-MEB (Netherlands)
Active substance
ACICLOVIR
Manufacturer
Healthypharm B.V.
Country
Netherlands (NL)
ATC code
D06BB03
ATC class
Aciclovir
Defined daily dose
25 mg, T
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    132583=21247

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

2 interactions on record for aciclovir.

Graded by severity as the source publishes them — 2 moderate. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check aciclovir against other medicinesHow interaction checks work

Aciclovir · interactions on record

2 records

  • 2 moderate

Most severe, free to view

  • Talimogene laherparepvecL01XL02moderate
  • Talimogen laherparepvecL01XX51moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same class

Other records under D06BB03

Aciclovir, as other registers publish it.

All aciclovir products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/dd8d4d8c-4c96-4372-852c-b1b5bd88a5b7
GET /v1/drugs/dd8d4d8c-4c96-4372-852c-b1b5bd88a5b7?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Crème",
  "route": "Cutaan gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h132583_smpc.pdf",
  "strength": null,
  "atc_label": "Aciclovir",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg132583",
  "excipients": [
    "CETYLALCOHOL",
    "DIMETICON (E 900)",
    "PARAFFINE, VLOEIBAAR (E905)",
    "PARAFFINE, ZACHT (E 905)",
    "PROPYLEENGLYCOL (E 1520)",
    "STEAROYLMACROGOLGLYCERIDEN",
    "WATER, GEZUIVERD"
  ],
  "substances": [
    "ACICLOVIR"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h132583.pdf",
  "authorised_at": "2023/12/11",
  "procedure_number": null,
  "dispensing_status": "Algemene verkoop [conform voorwaarden CBG AV-lijst d.d. 6 september 2007]",
  "registration_number": "132583=21247",
  "additional_monitoring": "N"
}
API referenceMCP serverPlans

See everything about aciclovir.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console